Description
| Product Name | Format | CAT.No | Size |
| Lambda Light Chains Immunoturbidimetric without sample pre-dilution | LS | BXC0381A | R1: 2 x 20ml R2: 1 x 8ml |
Product Description
The Biorex Diagnostics Lambda Light Chain Assay is a ready-to-use immunoturbidimetric test for the quantitative measurement of bound and free lambda light chains in human serum and plasma, providing essential information for haematological and immunological assessment. Immunoglobulin light chains are components of antibodies produced by plasma cells, and abnormal levels or imbalances between lambda and kappa light chains can indicate the presence of monoclonal gammopathies and other plasma cell disorders. Accurate measurement of lambda light chains, particularly in conjunction with kappa light chains and the lambda:kappa ratio, is critical for the detection, diagnosis, and monitoring of conditions such as multiple myeloma, Waldenström’s macroglobulinaemia, and lymphoproliferative disorders.
Key Features
- Quantitative determination of lambda light chains in serum and plasma
- Clinically relevant for multiple myeloma, Waldenström’s macroglobulinaemia, lymphocytic neoplasms, and autoimmune conditions
- Evaluation of lambda:kappa ratio for immune monitoring and monoclonal gammopathy detection
- Ready-to-use reagents simplify laboratory workflow, reduce preparation errors, and ensure consistent results
- Accurate, reproducible, and suitable for clinical diagnostics and research applications
Benefits
The Biorex Lambda Light Chain Assay delivers precise, reliable, and reproducible measurements, supporting diagnosis, disease monitoring, and research into plasma cell disorders and immune dysregulation. Its high analytical performance enables clinicians to detect abnormal light chain production and assess clonal plasma cell activity, aiding in the early identification of monoclonal gammopathies and related conditions. When used alongside kappa light chain measurements, the assay provides valuable insight into the lambda:kappa ratio, enhancing diagnostic accuracy and clinical interpretation.
This assay is particularly valuable in haematology laboratories, immunology departments, oncology clinics, and research institutions focused on plasma cell disorders and immune system abnormalities. Its ready-to-use format streamlines workflow, minimises pre-analytical variability, and ensures consistent performance across different laboratory settings. Compatibility with automated analysers supports efficient integration into routine clinical chemistry workflows, enabling high-throughput testing while maintaining accuracy and reliability.
In addition to clinical diagnostics, the Biorex Lambda Light Chain Assay supports research into immunoglobulin production, monoclonal gammopathies, and immune system function, making it an essential tool for advancing understanding of haematological and immunological diseases and improving patient outcomes.
Contact Us for more information.